Panacor Bioscience Ltd. is an emerging biopharmaceutical company focused on the development of innovative drug products that address unmet medical needs. The Company’s strategy is to acquire potential drug candidates and accelerate their development process towards commercialization with great success. The Company is strategically located in Asia and has access to early or mid-phase products from research institution to build a broad portfolio of products. It has also constructed an outsourcing development model to maximize efficiency, cost-savings and flexibility in the global new drug development arena.

With the management team’s extensive drug development, regulatory and global commercialization experience, the company has built an advanced product pipeline including one Phase III product and all the other products are with great blockbuster potential, promising the sustainable growth of the Company.